Skip to main navigation Skip to search Skip to main content

Residual tumour after biopsy for non‐palpable ductal carcinoma in situ of the breast

  • T. Wobbes*
  • , J. G. M. Tinnemans
  • , R. F. van der Sluis
  • *Corresponding author for this work
  • Radboud University Medical Center
  • Amsterdam UMC - University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In a group of 40 patients with non‐palpable ductal carcinoma in situ (DCIS) of the breast, 41 breast specimens were available for studying residual tumour after biopsy. In one group of ten patients seen before 1977, simple histological examination revealed a 9 per cent incidence of residual tumour. However, after thorough examination residual foci of DCIS were found in 77 per cent of a subsequent group of 30 patients. This means that the majority of patients would have had to undergo reoperation if a breast‐saving procedure had been performed. This fact must be taken into account when planning treatment of patients with non‐palpable DCIS. Copyright © 1989 British Journal of Surgery Society Ltd.
Original languageEnglish
Pages (from-to)185-186
JournalBritish journal of surgery
Volume76
Issue number2
DOIs
Publication statusPublished - 1989
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Residual tumour after biopsy for non‐palpable ductal carcinoma in situ of the breast'. Together they form a unique fingerprint.

Cite this